# How to use RamaXL

Source: https://www.keypedia.com/records/uk_mhra_guidance/uk-mhra/95d26196-5874-4d4f-917c-73ad8a60e37e
Type: Guidance
Published: January 27, 2015

> RamaXL is a subscription-based information service designed to provide organizations with streamlined access to regulatory data concerning products authorized in the United Kingdom. The platform offers two primary functions: it allows companies to access detailed information regarding their own product portfolios and provides non-confidential data on all other UK-authorized medicinal products. Although the provided text describes the service's features, subscription models, and fee structures, it does not include specific details typically associated with regulatory enforcement documents, such as inspection dates, identified violations, or mandatory corrective actions. In the context of the UK regulatory framework, RamaXL serves as a professional data management tool that assists organizations in monitoring product statuses and maintaining transparency within the industry. By consolidating proprietary and public product information into a single interface, the service helps stakeholders navigate the complexities of UK authorizations. While the text lacks mentions of specific MHRA or FDA inspections, the platform itself acts as a support system for compliance by ensuring organizations have ready access to the documentation required for their authorized activities. The service is aimed at professional entities looking to optimize their regulatory intelligence and data accessibility strategies.

---

## Content

RamaXL is a subscription service providing organisations with direct access to information on their own products and non-confidential information on all other products authorised in the UK. Find out more about its: features fees subscription

## Attachments

- [RamaXL](/government/publications/how-to-use-ramaxl/ramaxl)